Your version of Internet Explorer is outdated and needs to be updated!
Please upgrade to Internet Explorer 8 or Internet Explorer 9 to experience all the features of this site.

Charles Peloquin , Pharm.D.

Charles Peloquin

Professor

Department of Pharmacotherapy and Translational Research

OFFICE: HSC P4-33

EMAIL: peloquin@cop.ufl.edu

PHONE: 352-273-6266

 

Education

  • Pharm.D., Philadelphia College of Pharmacy and Science
  • B.S. in Pharmacy, University of Connecticut

Biographical Sketch

Prior to coming to the University of Florida, Peloquin completed a hospital pharmacy residency at Duke University Medical Center, where he also served on the clinical staff.  Peloquin completed a fellowship in Infectious Diseases and Pharmacokinetics at the Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital, Buffalo, N.Y.  For 20 years, he was the Director of the Infectious Disease Pharmacokinetics Laboratory (IDPL) at National Jewish Medical and Research Center, Denver, CO.  He now serves as Professor of Pharmacy and Medicine at UF, where the IDPL is now located.  Peloquin and his lab are part of the UF Emerging Pathogens Institute.  He also is a consultant to the FDA and CDC.

Affiliations

American College of Clinical Pharmacy
American Society of Microbiology
Society of Infectious Disease Pharmacists
International Society of Antimicrobial Pharmacology

RESEARCH INTERESTS

  • Peloquin’s laboratory serves as a national reference center for the determination of serum concentrations for the antimycobacterial, antifungal, and anti-HIV drugs, as well as linezolid. His research efforts focus on therapeutic drug monitoring and clinical trials for patients with advanced mycobacterial diseases.

Publications

Ahmad Z, Peloquin CA, Singh RP, et al. PA-824 exhibits time-dependent activity in a murine model of tuberculosis, Antimicrob Agents Chemother, 2010 Oct 11.

Sung JC, Garcia-Contreras L, VerBerkmoes JL, Peloquin CA, et al. Dry powder nitroimidazopyran antibiotic PA-824 aerosol for inhalation, Antimicrobial Agents and Chemotherapy, 2009; 53:1338-1343.

Dietz R, Hadad DJ, McGee B, Molino LP, Maciel ELN, Peloquin CA, et al. Early and Extended Early Bactercidal Activity of Linezolid in Pulmonary Tuberculosis, Am J Respir Crit Care Med, 2008 Dec 1;178(11):1180-1185.

Dooley K, Klexner C, Hackman J, Peloquin C, et al. High-dose intermittent rifapentine induces its own metabolism and that of moxifloxacin, Antimicrobial Agents and Chemotherapy, 2008 Sep 2.

Full Publication List via PubMed RSS feed

 
 
Top of Page